DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma

BACKGROUND: Deoxycytidine kinase (DCK), an enzyme in the nucleoside biosynthetic pathway, can affect the development of immune cells. However, the relationships between the expression of DCK, patient prognosis, and tumor-infiltrating immune cells (TIICs) in hepatocellular carcinoma (HCC) are still u...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Danjun, Wang, Yining, Zhu, Kai, Tian, Lingyu, Gao, Qiang, Zhou, Jian, Fan, Jia, Wang, Xiaoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372783/
https://www.ncbi.nlm.nih.gov/pubmed/32690026
http://dx.doi.org/10.1186/s12957-020-01953-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372783/
https://www.ncbi.nlm.nih.gov/pubmed/32690026
http://dx.doi.org/10.1186/s12957-020-01953-1

Ejemplares similares